PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity
Clinical trial NCT04621136 · COMPLETED
Trial details
- NCT number
- NCT04621136
- Sponsor
- Kyushu University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2022-11-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.